Odonate Therapeutics, Inc.

Having jumped in front of the UK's Redx Pharma Plc to snap up Jounce Therapeutics, Inc. , Concerta Biosciences is looking to bag another embattled biotech, making a bid for the US antiviral speci

Less than a month after laying off half its staff and leaping onto a life raft thrown by Redx Pharma Plc , Jounce Therapeutics, Inc. has received a takeover offer from another suitor, little-known

The summer of 2020 has been a busy one for US biopharmaceutical company initial public offerings, but after 14 in June and 12 in July there were just six in August – although that’s still the third mo

Odonate Therapeutics, Inc. is edging closer to bringing its first cancer therapy to market. Tesetaxel, a next-generation chemotherapy, could have convenience and tolerability benefits over older taxa